PPG-3 Glyceryl Ether Triacrylate is the organic compound that conforms to the formula.
定义
美国FDA 物质登记 · UNII NQ23FMS7BT · 登记名称 PPG-3 GLYCERYL TRIACRYLATE · 单一化学物质
PPG-3 Glyceryl Ether Triacrylate is the organic compound that conforms to the formula.
化妆品中的作用
在涂抹处形成薄膜FILM FORMING
安全与法规参考
未列入韩国有毒物质 GHS 分类 · 现有化学物质
详细资料——标示名称、识别编号、物性、试验记录、文献
官方标示名称和定义
日本化妆品工业联合会标示名称 トリアクリル酸ＰＰＧ－３グリセリルエーテル: 本品は、次の化学式で表される有機化合物である。
来源: 日本化妆品工业联合会标示名称
别名和识别信息
PPG-3 GLYCERYL ETHER TRIACRYLATEINCI피피지-3글리세릴에터트라이아크릴레이트韩国标示名称（食药处标准名）Poly[oxy(methyl-1,2-ethanediyl)], .alpha.,.alpha.',.alpha.''-1,2,3-propanetriyltris[.omega.1-(1-oxo-2-propenyl)oxy]-同义名トリアクリル酸ＰＰＧ－３グリセリルエーテル日本标示名称
- CAS No.化学物质登记号
- 52408-84-1
- DTXSID美国EPA化学品编号
- DTXSID50894416
- DTXCID美国EPA化合物编号
- DTXCID001777260
- 分子式
- (C3H4O)n(C3H4O)n(C3H4O)nC12H11O6
产品实际使用的用途
刺激与致敏试验记录
记录有皮肤试验 7 项、眼部试验 5 项。
归类为刺激性高1 项归类为低8 项
各项试验结论不一（最多的结论占 11%），因此不能断定该成分有刺激性。 这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。
查看全部 12 项试验
- Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: according to U.S. Federal Register, Vol. 38, No. 1,87, Section 1500 : 41, 1973. equivalent or similar to - Ambiguous
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation) - Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Method according to Fed.Reg. 38, No. 187, para 1500.41 S. 27019 vom 27.09.73 equivalent or similar to - Category 6.3A (Category 2)
Skin Irritation · Read Across - High Frequency of Sensitization
skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) - Severe Irritation
eye irritation: in vivo · Screening · other guideline: followed procedures based on the methods described in FIFRA (Federal Insecticide, Fungicide, and Rodenticide Act) according to - Ambiguous
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Category 6.4A (Category 2A)
Eye Irritation · Read Across - Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to - Moderate or Mild Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
来源: 美国EPA CompTox